Mitigation of Experimental Allergic Encephalomyelitis by Cathepsin D Inhibition (Q40737588)

23 September 2017

title

Mitigation of Experimental Allergic Encephalomyelitis by Cathepsin D Inhibition (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

13 March 2023

author name string

D. H. Boehme

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A317560

13 March 2023

N. Marks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A317560

13 March 2023

language of work or name

English

0 references

publication date

1 January 1979

1 reference

full work available at URL

23 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

http://link.springer.com/content/pdf/10.1007/978-1-4684-8914-9_30

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Advances in Experimental Medicine and Biology

13 March 2023

published in

1 reference

23 September 2017

volume

121B

1 reference

23 September 2017

page(s)

317-323

1 reference

ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

23 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Metabolic Instability of Myelin Proteins. Breakdown of Basic Protein Induced by Brain Cathepsin D

13 March 2023

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Proteolytic activity in brain and spinal cord in sensitive and resistant strains of rat and mouse subjected to experimental allergic encephalomyelitis

13 March 2023

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Direct evidence of importance of lysosomes in degradation of intracellular proteins

13 March 2023

5

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Inhibition by pepstatin of human cartilage degradation

13 March 2023

6

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Treatment of Experimental Allergic Encephalomyelitis with Encephalitogenic Basic Proteins

13 March 2023

9

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Pentapeptide (pepstatin) inhibition of brain acid proteinase

13 March 2023

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Proteolytic enzymes in ordinary, hyperacute, monocytic and passive transfer forms of experimental allergic encephalomyelitis

13 March 2023

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Effects of protease inhibitors on liver regeneration

13 March 2023

14

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

The role of proteolytic enzymes in demyelination in experimental allergic encephalomyelitis

13 March 2023

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

Muscular Dystrophy: Inhibition of Degeneration in Vivo with Protease Inhibitors

13 March 2023

17

1 reference

https://api.crossref.org/works/10.1007/978-1-4684-8914-9_30

13 March 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=317560

13 March 2023

1 reference